Literature DB >> 26153285

Perinatal management of fetal supraventricular tachycardia complicated by maternal pertussis.

Stephanie Dejong1, Bahram Salmanian2, Alireza A Shamshirsaz2, Rodrigo Ruano2.   

Abstract

Prenatal pertussis has become a concern once again with the reappearance of the disease in the USA. A 30-year-old mother whose pregnancy was complicated with fetal arrhythmia was referred for further evaluation in the third trimester. After initial treatment with antiarrhythmic medications due to continued irregular rhythm, she was revisited for persistent hacking cough at 38 weeks gestational age. PCR examination confirmed pertussis diagnosis. Owing to increased risk of digoxin toxicity with concurrent antibiotic administration, antiarrhythmic medication was discontinued. Delivery was induced 2 days after the initiation of azithromycin therapy to prevent the transmission of the disease to the neonate. A well-planned delivery in a patient with prenatal diagnosis prevents neonatal infection while considering the obstetrical dilemma for concurrent management of the intrauterine arrhythmia and antibiotic administration. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26153285      PMCID: PMC4499762          DOI: 10.1136/bcr-2015-209909

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection.

Authors:  Luis A Castagnini; C Mary Healy; Marcia A Rench; Susan H Wootton; Flor M Munoz; Carol J Baker
Journal:  Clin Infect Dis       Date:  2011-11-10       Impact factor: 9.079

2.  Infant pertussis: what to do next?

Authors:  C Mary Healy; Carol J Baker
Journal:  Clin Infect Dis       Date:  2011-12-08       Impact factor: 9.079

3.  Public health. The pertussis paradox.

Authors:  Arthur Allen
Journal:  Science       Date:  2013-08-02       Impact factor: 47.728

4.  Macrolide-induced digoxin toxicity: a population-based study.

Authors:  T Gomes; M M Mamdani; D N Juurlink
Journal:  Clin Pharmacol Ther       Date:  2009-07-15       Impact factor: 6.875

Review 5.  Role of maternal pertussis antibodies in infants.

Authors:  Annelies Van Rie; Aaron M Wendelboe; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

6.  Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.

Authors:  C Mary Healy; Marcia A Rench; Carol J Baker
Journal:  Clin Infect Dis       Date:  2012-10-24       Impact factor: 9.079

7.  ACOG Committee Opinion No. 566: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-06       Impact factor: 7.661

8.  Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

Authors:  Lara K Misegades; Kathleen Winter; Kathleen Harriman; John Talarico; Nancy E Messonnier; Thomas A Clark; Stacey W Martin
Journal:  JAMA       Date:  2012-11-28       Impact factor: 56.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.